Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective study
Abstract Background Uremic neuropathy is a distal sensorimotor polyneuropathy caused by uremic toxins; its severity is correlated with the degree of renal insufficiency. Erythropoietin (EPO) and erythropoietin receptors (EpoR) are produced in the peripheral nervous system. This is a single-center op...
Main Authors: | Amal T. Khafagi, Mohamed A. Yehia, Amal K. Helmy, Waleed Hassan, Nashwa Abdelhakim |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-05-01
|
Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41983-022-00477-7 |
Similar Items
-
Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome
by: Da Eun Woo, et al.
Published: (2016-02-01) -
Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-06-01) -
Uremic Optic Neuropathy: A Potentially Reversible Complication of Chronic Kidney Disease
by: Niranjan Raja, et al.
Published: (2022-03-01) -
Intravenous plus intravitreal erythropoietin for management of methanol toxicity optic neuropathy: A case report and brief review
by: Mehran Rashidi Alavijeh, et al.
Published: (2023-03-01) -
Erythropoietin Protects against Retinal Damage in A Rat Model of Optic Neuropathy via Glial Suppression
by: Atiyeh Eghbali, et al.
Published: (2023-05-01)